Search results
The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system diseases.
Learn more about our portfolio of specialty medicines in nephrology, oncology, immunology & allergy, and neurology. Join us to grow your career or partner with us to propel your research discoveries into the hands of patients and physicians.
Kyowa Kirin is an R&D-based life sciences company with special strengths in biotechnology. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies.
Kyowa Kirin Co., Ltd. (協和キリン株式会社, Kyōwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue.
Through a robust pipeline of promising drug candidates, pharmaceutical innovator Kyowa Kirin aims to ensure people around the world have access to safe, effective treatment. This page describes the company's research, technologies, and development schedules.
May 14, 2024 · Founded in 1949, Kyowa Kirin has a successful track record in Japan and is now expanding globally. Our areas of focus include rare diseases, haemato-oncology and intractable haematologic diseases and bone and mineral diseases, whilst leveraging innovative modalities for drug discovery and novel therapies in advanced antibody technology and ...
Kyowa Kirin International plc is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs.
